SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-045775
Filing Date
2018-02-14
Accepted
2018-02-14 16:56:28
Documents
1
Group Members
JOHN S. CLARK IISOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP, LLCSOUTHPOINT GP, LPSOUTHPOINT MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G d504024dsc13g.htm SC 13G 124961
  Complete submission text file 0001193125-18-045775.txt   126960
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80470 | Film No.: 18613174
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1114 AVENUE OF THE AMERICAS 22ND FLOOR NEW YORK NY 10036
Business Address 1114 AVENUE OF THE AMERICAS 22ND FLOOR NEW YORK NY 10036 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

IRS No.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G